Fisher Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-368,257	Closed	-$43.7M	–	1019
2022 Q1	$43.7M	Sell	368,257 -4,281	-1%	-$508K	0.03%	254
2021 Q4	$51.3M	Buy	372,538 +104,562	+39%	+$14.4M	0.03%	243
2021 Q3	$37.2M	Buy	+267,976	New	+$37.2M	0.02%	261